Technological innovation is the growth strategy of the member companies of the Plasma Protein Therapeutics Association. Refining the methods for the production of plasma-based and recombinant therapies has helped to establish the PPTA members as leaders in biotechnology. By setting new standards in the areas of collection and manufacturing, environmental, health and safety performance, PPTA companies must participate in continuous process improvement.
In order to achieve the highest levels of quality, PPTA members undergo rigorous manufacturing practices.
To understand the science of the lifesaving therapies, see the following charts to review the processes for the manufacturing and the collection of source plasma.
Other PPTA educational websites available to physicians and healthcare professionals on the use of albumin and fluid resuscitation as well as overall fluid management strategies and techniques are www.fluidtherapy.net and www.albumin-ppta.com.